Atıf İçin Kopyala
Ilgin B. U., Koyuncu I. M. A., Kızıltunç E.
ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.25, sa.3, ss.184-190, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
25
Sayı:
3
-
Basım Tarihi:
2021
-
Doi Numarası:
10.14744/anatoljcardiol.2020.79138
-
Dergi Adı:
ANATOLIAN JOURNAL OF CARDIOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.184-190
-
Anahtar Kelimeler:
COVID-19, SARS-CoV-2, coronavirus, antimicrobial therapy, ECG, QT INTERVAL, RISK
-
Gazi Üniversitesi Adresli:
Evet
Özet
Objective: The effects of treatment of coronavirus disease 2019 (COVID-19) with a triple combination composed of hydroxychloroquine, an antiviral, and an antibiotic on electrocardiography (ECG) parameters in patients with mild-to-moderate symptoms are not wholly understood. We aimed to explore the changes in ECG parameters after treatment with triple combination therapy in patients with mild-to-moderate symptomatic COVID-19.